Recombinant human IFNL1 (NP_742152.1) (Met1-Thr200) was expressed with an initial Met.
Predicted N Terminal:
Lyophilized from sterile PBS, pH 7.4, 5%~8% trehalose and mannitol.
Measured in antiviral assays using HepG2 cells infected with vesicular stomatitis virus. The ED50 for this effect is typically 10-39 ng/mL.
The recombinant human IFNL1 consists 182 amino acids and predicts a molecular mass of 20.2 kDa.
< 1.0 EU per μg of the protein as determined by the LAL method.
>(80.7+15.8) % as determined by SDS-PAGE.
Samples are stable for up to twelve months from date of receipt at -70ºC.
Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 ug/ul. Centrifuge the vial at 4ºC before opening to recover the entire contents.